Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting — Stella

Recruiting

Back to Deep Vein Thrombosis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

The First Affliated Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang

Key details

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

Zhejiang University, Ningbo No.2 Hospital

Enrollment target

~172 participants

Started

November 2021

Primary completion

December 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov